SCHEMBL6424905

SCHEMBL6424905

CCCCCCC=C1Oc2cccc(O)c2C1=O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TYR P14679 4/20 0.51
CES2 O00748 1/20 0.43
ABCC2 Q92887 5/20 0.41
ELANE P08246 2/20 0.41
CTSG P08311 2/20 0.41
STK17B O94768 1/20 0.39
MMP2 P08253 2/20 0.39
F7 P08709 2/20 0.39
F3 P13726 2/20 0.39
MAPT P10636 2/20 0.39
KDM4E B2RXH2 1/20 0.39
ALOX15 P16050 1/20 0.39
ECE1 P42892 1/20 0.39
SGMS1 Q86VZ5 1/20 0.39
SGMS2 Q8NHU3 1/20 0.39
MUS81 Q96NY9 1/20 0.39
HSD17B10 Q99714 1/20 0.39
SAE1 Q9UBE0 1/20 0.39
MEN1 O00255 1/20 0.38
ALDH1A1 P00352 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6820553 0.74 TYR (0.55) TYRABCC2STK17BPIK3CAMTOR
SCHEMBL8943228 0.74 TRPA1 (0.44) TYRCES2ELANECTSGMAPT
SCHEMBL8943219 0.74 TRPA1 (0.44) TYRCES2ELANECTSGMAPT
SCHEMBL6823700 0.73 TYR (0.53) TYRABCC2STK17BPIK3CAMTOR
SCHEMBL6824393 0.72 TYR (0.58) TYRSTK17BMAPTKDM4EALDH1A1
SCHEMBL6824396 0.72 TYR (0.58) TYRSTK17BMAPTKDM4EALDH1A1
SCHEMBL7788343 0.71 TYR (0.51) TYRALDH1A1
SCHEMBL7788402 0.71 TYR (0.51) TYRALDH1A1
SCHEMBL3751329 0.68 TRPA1 (0.62) ELANECTSGMAPTKDM4EALOX15
SCHEMBL6424903 0.68 TYR (0.43) TYRCES2ELANECTSGSTK17B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1012147-B1 O-SUBSTITUTED HYDROXYCUMARANONE DERIVATIVES AS ANTITUMOR AND ANTIMETASTATIC AGENTS HOFFMANN LA ROCHE (CH) 2005-11-02 EP disclosed
US-6200989-B1 ADMINISTERING AS UROKINASE PLASMINOGEN ACTIVATOR ANTAGONISTS, ANTITUMOR AND ANTIMETASTASIS AGENTS HOFFMANN-LA ROCHE INC. 2001-03-13 US disclosed
EP-1012147-A2 O-SUBSTITUTED HYDROXYCUMARANONE DERIVATIVES AS ANTITUMOR AND ANTIMETASTATIC AGENTS F. HOFFMANN-LA ROCHE AG (CH) 2000-06-28 EP disclosed
WO-1999006387-A2 O-SUBSTITUTED HYDROXYCUMARANONE DERIVATIVES AS ANTITUMOR AND ANTIMETASTATIC AGENTS F. HOFFMANN-LA ROCHE AG (CH) 1999-02-11 WO disclosed